TC BioPharm's Series A Round

TC BioPharm raised a round of funding on February 01, 2017.

TC BioPharm is an immunotherapy and clinical development company with a cell-based product pipeline capable of treating a variety of disorders including cancer and severe viral infections. Its lead pr…

Articles about TC BioPharm's Series A Round: